Question 1

Does National Bank of Canada own ABCL stock?

Accepted Answer

Yes. As of its Q2 2026 13F, National Bank of Canada holds 1,233,014 shares of ABCL (Abcellera Biologics), worth $9.7M.

Question 2

How many shares of ABCL does National Bank of Canada own?

Accepted Answer

As of its Q2 2026 13F, National Bank of Canada holds 1,233,014 shares of ABCL (Abcellera Biologics).

Question 3

What is National Bank of Canada's ABCL position worth?

Accepted Answer

As of its Q2 2026 13F, National Bank of Canada's ABCL position is worth $9.7M.

Question 4

Is National Bank of Canada buying or selling ABCL?

Accepted Answer

In Q2 2026, National Bank of Canada increased its ABCL position from 1,393 to 1,233,014 shares.

Question 5

When did National Bank of Canada first buy ABCL?

Accepted Answer

National Bank of Canada already held ABCL in its Q4 2021 13F, the earliest on record, and has listed it in 18 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.2M	+884x	$9.7M	0.0%	$7.85	45
2026-Q1	New	1,393	-	$4,862	0.0%	$3.71	23
2025-Q4	Exited	0	-100.0%	$0	0.0%	$3.45	0
2025-Q3	Increased	3,447	+3151.9%	$17,278	0.0%	$4.87	20
2025-Q2	Decreased	106	-96.7%	$331	0.0%	$3.61	0
2025-Q1	Decreased	3,233	-95.7%	$7,145	0.0%	$2.31	0
2024-Q4	Increased	74,901	+15.1%	$219,460	0.0%	$2.82	26
2024-Q3	Increased	65,097	+66.5%	$169,252	0.0%	$2.61	33

ABCLShowing 8 of 19 quarters

ABCL
Showing 8 of 19 quarters